146 related articles for article (PubMed ID: 9796256)
1. [A clinical study on renal pelvic and ureteral cancer--with special reference to prognostic factors and adjuvant chemotherapy].
Miyagawa Y; Oka T; Seko M; Tei N; Satoh E; Takano Y; Tsujimura A; Takaha M; Takeda M
Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):766-73. PubMed ID: 9796256
[TBL] [Abstract][Full Text] [Related]
2. [A clinical study on renal pelvic and ureteral cancer].
Sato E; Ishii A; Kunitomi K; Ishito N; Takamoto H; Araki T
Hinyokika Kiyo; 2002 Dec; 48(12):735-9. PubMed ID: 12613007
[TBL] [Abstract][Full Text] [Related]
3. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Kobayashi H; Obata K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S14-7. PubMed ID: 7994781
[TBL] [Abstract][Full Text] [Related]
4. [Clinical investigation of renal pelvic and ureteral cancer with special reference to adjuvant chemotherapy].
Shinohara M; Okazawa A; Suzuki M; Itakura H; Munakata A; Kinoshita K
Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1375-82. PubMed ID: 7474622
[TBL] [Abstract][Full Text] [Related]
5. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Kume T; Masu C; Ishino T; Nakatsu H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
[TBL] [Abstract][Full Text] [Related]
6. The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
Miyanaga N; Akaza H; Shimazui T; Ohtani M; Koiso K
Cancer Chemother Pharmacol; 1994; 35 Suppl():S5-8. PubMed ID: 7527735
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of postoperative adjuvant chemotherapy in patients with transitional cell carcinoma of the upper urothelium. Nara Urooncology Research Group (NUORG)].
Uemura H; Ozono S; Hayashi Y; Hirao Y; Okajima E; Aoyoma H; Sasaki K; Ohara S; Hashimoto M; Yoshikawa M
Nihon Hinyokika Gakkai Zasshi; 1991 Aug; 82(8):1273-80. PubMed ID: 1921019
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation on renal pelvic and ureteral tumors].
Miyagi T; Oshinoya Y; Shimamura M
Hinyokika Kiyo; 1990 Nov; 36(11):1261-6. PubMed ID: 2288306
[TBL] [Abstract][Full Text] [Related]
9. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for poor prognosis patients with urothelial tumors and effect of dose intensity.
Hibi H; Okamura K; Takashi M; Shimoji T; Miyake K
Hinyokika Kiyo; 1997 Feb; 43(2):89-96. PubMed ID: 9086342
[TBL] [Abstract][Full Text] [Related]
10. Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response.
Igawa M; Urakami S; Shiina H; Ishibe T; Kadena H; Usui T
Br J Urol; 1995 Sep; 76(3):321-4. PubMed ID: 7551840
[TBL] [Abstract][Full Text] [Related]
11. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
Shishido S; Hayakawa M; Higa I; Koyama Y; Hatano T; Osawa A
Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
14. [A clinical investigation on renal pelvic and ureteral tumors].
Okuno T; Hioki T; Kameda K; Satani H; Yamashita A; Sugimura Y; Tochigi H; Kawamura J; Tazima K
Hinyokika Kiyo; 1991 Aug; 37(8):851-6. PubMed ID: 1957727
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
[TBL] [Abstract][Full Text] [Related]
17. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
Seguchi T; Nakano E; Miki T; Kondoh M; Nishimura K; Nakamura N; Okuyama A
Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance gene product (P-glycoprotein) in transitional cell carcinomas of the upper urinary tract.
Shinohara N; Nonomura K; Takakura F; Hamada M; Grossman HB; Koyanagi T
Eur Urol; 1994; 26(4):327-33. PubMed ID: 7713132
[TBL] [Abstract][Full Text] [Related]
19. [A clinical study of renal pelvic and ureteral cancer: prognosis and frequency of subsequent bladder cancer following surgical treatment].
Watanabe M; Hayashi T; Takamatsu M; Kamitani A; Inoue M; Morisue K; Irie S; Kaneshige T
Nihon Hinyokika Gakkai Zasshi; 2003 Mar; 94(3):428-33. PubMed ID: 12710077
[TBL] [Abstract][Full Text] [Related]
20. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
